Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 352

1.

Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults.

Gallieni M, Hollenbeck M, Inston N, Kumwenda M, Powell S, Tordoir J, Al Shakarchi J, Berger P, Bolignano D, Cassidy D, Chan TY, Dhondt A, Drechsler C, Ecder T, Finocchiaro P, Haller M, Hanko J, Heye S, Ibeas J, Jemcov T, Kershaw S, Khawaja A, Labriola L, Lomonte C, Malovrh M, Marti I Monros A, Matthew S, McGrogan D, Meyer T, Mikros S, Nistor I, Planken N, Roca-Tey R, Ross R, Troxler M, van der Veer S, Vanholder R, Vermassen F, Welander G, Wilmink T, Koobasi M, Fox J, Van Biesen W, Nagler E.

Nephrol Dial Transplant. 2019 Jun 1;34(Supplement_2):ii1-ii42. doi: 10.1093/ndt/gfz072. No abstract available.

PMID:
31192372
2.

The new European Renal Best Practice guideline on arteriovenous access: why worthwhile to read.

Vanholder R, Van Biesen W, Fox JG, Nagler EV.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1071-1074. doi: 10.1093/ndt/gfz118. No abstract available.

PMID:
31190056
3.

Estimating the Level of Carbamoylated Plasma Non-High-Density Lipoproteins Using Infrared Spectroscopy.

Delanghe SE, De Bruyne S, De Baene L, Van Biesen W, Speeckaert MM, Delanghe JR.

J Clin Med. 2019 May 31;8(6). pii: E774. doi: 10.3390/jcm8060774.

4.

Evolution Over Time of Volume Status and PD-Related Practice Patterns in an Incident Peritoneal Dialysis Cohort.

Van Biesen W, Verger C, Heaf J, Vrtovsnik F, Britto ZML, Do JY, Prieto-Velasco M, Martínez JP, Crepaldi C, De Los Ríos T, Gauly A, Ihle K, Ronco C; IPOD-PD Study Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):882-893. doi: 10.2215/CJN.11590918. Epub 2019 May 23.

PMID:
31123180
5.

The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.

Gielis EM, Ledeganck KJ, Dendooven A, Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D.

Nephrol Dial Transplant. 2019 May 18. pii: gfz091. doi: 10.1093/ndt/gfz091. [Epub ahead of print]

PMID:
31106364
6.

A swan song for Kt/Vurea.

Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2019 Apr 25. doi: 10.1111/sdi.12811. [Epub ahead of print] Review.

PMID:
31025455
7.

Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.

Snauwaert E, Holvoet E, Van Biesen W, Raes A, Glorieux G, Vande Walle J, Roels S, Vanholder R, Askiti V, Azukaitis K, Bayazit A, Canpolat N, Fischbach M, Godefroid N, Krid S, Litwin M, Obrycki L, Paglialonga F, Ranchin B, Samaille C, Schaefer F, Schmitt CP, Spasojevic B, Stefanidis CJ, Van Dyck M, Van Hoeck K, Collard L, Eloot S, Shroff R.

Toxins (Basel). 2019 Apr 24;11(4). pii: E235. doi: 10.3390/toxins11040235.

8.

Increasing access to integrated ESKD care as part of universal health coverage.

Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O'Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit.

Kidney Int. 2019 Apr;95(4S):S1-S33. doi: 10.1016/j.kint.2018.12.005. Review.

PMID:
30904051
9.

Evaluation with micro-CT of different anticoagulation strategies during hemodialysis in patients with thrombocytopenia: A randomized crossover study.

Vanommeslaeghe F, De Somer F, Josipovic I, Boone M, Dhondt A, Van Biesen W, Eloot S.

Artif Organs. 2019 Feb 28. doi: 10.1111/aor.13452. [Epub ahead of print]

PMID:
30820962
10.

A systematic review of patient participation during bedside handovers on wards with older patients indicates evidence is urgently needed.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Int J Older People Nurs. 2019 Jun;14(2):e12226. doi: 10.1111/opn.12226. Epub 2019 Feb 15. No abstract available.

11.

Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?

Van Biesen W, Eloot S.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):324-326. doi: 10.2215/CJN.00500119. Epub 2019 Feb 6. No abstract available.

PMID:
30728168
12.

Reporting of "dialysis adequacy" as an outcome in randomised trials conducted in adults on haemodialysis.

Steyaert S, Holvoet E, Nagler E, Malfait S, Van Biesen W.

PLoS One. 2019 Feb 5;14(2):e0207045. doi: 10.1371/journal.pone.0207045. eCollection 2019.

13.

Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.

INTEGRATED group consists of (in alphabetical order), Chan C, Combes G, Davies S, Finkelstein F, Firanek C, Gomez R, Jager KJ, George VJ, Johnson DW, Lambie M, Madero M, Masakane I, McDonald S, Misra M, Mitra S, Moraes T, Nadeau-Fredette AC, Mukhopadhyay P, Perl J, Pisoni R, Robinson B, Ryu DR, Saran R, Sloand J, Sukul N, Tong A, Szeto CC, Van Biesen W.

Perit Dial Int. 2019 Jan-Feb;39(1):4-12. doi: 10.3747/pdi.2017.00242. Review.

14.

The effectiveness of bedside handovers: A multilevel, longitudinal study of effects on nurses and patients.

Malfait S, Eeckloo K, Van Biesen W, Van Hecke A.

J Adv Nurs. 2019 Jan 21. doi: 10.1111/jan.13954. [Epub ahead of print]

PMID:
30666713
15.

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R.

Int Urol Nephrol. 2019 Feb;51(2):293-302. doi: 10.1007/s11255-018-2056-x. Epub 2019 Jan 2.

PMID:
30604232
16.

Development of an International Standard Set of Value-Based Outcome Measures for Patients With Chronic Kidney Disease: A Report of the International Consortium for Health Outcomes Measurement (ICHOM) CKD Working Group.

Verberne WR, Das-Gupta Z, Allegretti AS, Bart HAJ, van Biesen W, García-García G, Gibbons E, Parra E, Hemmelder MH, Jager KJ, Ketteler M, Roberts C, Al Rohani M, Salt MJ, Stopper A, Terkivatan T, Tuttle KR, Yang CW, Wheeler DC, Bos WJW.

Am J Kidney Dis. 2019 Mar;73(3):372-384. doi: 10.1053/j.ajkd.2018.10.007. Epub 2018 Dec 20.

17.

An International Analysis of Dialysis Services Reimbursement.

van der Tol A, Lameire N, Morton RL, Van Biesen W, Vanholder R.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):84-93. doi: 10.2215/CJN.08150718. Epub 2018 Dec 13.

PMID:
30545819
18.

Subclinical AKI: ready for primetime in clinical practice?

Vanmassenhove J, Van Biesen W, Vanholder R, Lameire N.

J Nephrol. 2019 Feb;32(1):9-16. doi: 10.1007/s40620-018-00566-y. Epub 2018 Dec 6. Review.

PMID:
30523562
19.

Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.

Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ.

PLoS One. 2018 Dec 6;13(12):e0208207. doi: 10.1371/journal.pone.0208207. eCollection 2018.

20.

Gut microbiota dynamics and uraemic toxins: one size does not fit all.

Joossens M, Faust K, Gryp T, Nguyen ATL, Wang J, Eloot S, Schepers E, Dhondt A, Pletinck A, Vieira-Silva S, Falony G, Vaneechoutte M, Vanholder R, Van Biesen W, Huys GRB, Raes J, Glorieux G.

Gut. 2018 Nov 21. pii: gutjnl-2018-317561. doi: 10.1136/gutjnl-2018-317561. [Epub ahead of print] No abstract available.

21.

Transport of neutral IgG2 versus anionic IgG4 in PD: implications on the electrokinetic model.

Pletinck A, Van Biesen W, Dequidt C, Eloot S.

BMC Nephrol. 2018 Oct 29;19(1):299. doi: 10.1186/s12882-018-1104-1.

22.

Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop.

Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, Tugwell P, Pecoits-Filho R, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Levin A, Thompson A, Perkovic V, Ju A, Gutman T, Bernier-Jean A, Viecelli AK, O'Lone E, Shen J, Josephson MA, Cho Y, Johnson DW, Sautenet B, Tonelli M, Craig JC; SONG Implementation Workshop Investigators.

Kidney Int. 2018 Dec;94(6):1053-1068. doi: 10.1016/j.kint.2018.08.018. Epub 2018 Oct 22.

PMID:
30360959
23.

Treating potassium disturbances: kill the killers but avoid overkill.

Vanholder R, Van Biesen W, Nagler EV.

Acta Clin Belg. 2019 Aug;74(4):215-228. doi: 10.1080/17843286.2018.1531206. Epub 2018 Oct 24.

PMID:
30353786
24.

Do Bedside Handovers Reduce Handover Duration? An Observational Study With Implications for Evidence-Based Practice.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Worldviews Evid Based Nurs. 2018 Dec;15(6):432-439. doi: 10.1111/wvn.12330. Epub 2018 Oct 15.

PMID:
30320971
25.

The effects of aerobic exercise on eGFR, blood pressure and VO2peak in patients with chronic kidney disease stages 3-4: A systematic review and meta-analysis.

Vanden Wyngaert K, Van Craenenbroeck AH, Van Biesen W, Dhondt A, Tanghe A, Van Ginckel A, Celie B, Calders P.

PLoS One. 2018 Sep 11;13(9):e0203662. doi: 10.1371/journal.pone.0203662. eCollection 2018.

26.

Is privacy a problem during bedside handovers? A practice-oriented discussion paper.

Malfait S, Van Hecke A, Van Biesen W, Eeckloo K.

Nurs Ethics. 2018 Aug 22:969733018791348. doi: 10.1177/0969733018791348. [Epub ahead of print]

PMID:
30134750
27.

Interventions for chronic non-hypovolaemic hypotonic hyponatraemia.

Nagler EV, Haller MC, Van Biesen W, Vanholder R, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2018 Jun 28;6:CD010965. doi: 10.1002/14651858.CD010965.pub2. Review.

28.

Thrombomodulin and Endothelial Dysfunction: A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.

Demeulenaere M, Devreese K, Vanbelleghem H, De Zaeytijd J, Vande Walle J, Van Biesen W, Van Laecke S.

Nephron. 2018;140(1):63-73. doi: 10.1159/000490201. Epub 2018 Jun 25.

29.

Compliance with a structured bedside handover protocol: An observational, multicentred study.

Malfait S, Eeckloo K, Van Biesen W, Deryckere M, Lust E, Van Hecke A.

Int J Nurs Stud. 2018 Aug;84:12-18. doi: 10.1016/j.ijnurstu.2018.04.011. Epub 2018 Apr 24.

PMID:
29729557
30.

Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview study.

Tong A, Crowe S, Gill JS, Harris T, Hemmelgarn BR, Manns B, Pecoits-Filho R, Tugwell P, van Biesen W, Wang AYM, Wheeler DC, Winkelmayer WC, Gutman T, Ju A, O'Lone E, Sautenet B, Viecelli A, Craig JC.

BMJ Open. 2018 Apr 20;8(4):e021198. doi: 10.1136/bmjopen-2017-021198.

31.

Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe.

Brück K, Jager KJ, Zoccali C, Bello AK, Minutolo R, Ioannou K, Verbeke F, Völzke H, Arnlöv J, Leonardis D, Ferraro PM, Brenner H, Caplin B, Kalra PA, Wanner C, Castelao AM, Gorriz JL, Hallan S, Rothenbacher D, Gibertoni D, De Nicola L, Heinze G, Van Biesen W, Stel VS; European CKD Burden Consortium.

Kidney Int. 2018 Jun;93(6):1432-1441. doi: 10.1016/j.kint.2018.01.008. Epub 2018 Apr 12.

PMID:
29656901
32.

Haste makes waste-Should current guideline recommendations for initiation of renal replacement therapy for acute kidney injury be changed?

Vanmassenhove J, Vanholder R, Van Biesen W, Lameire N.

Semin Dial. 2018 May;31(3):204-208. doi: 10.1111/sdi.12693. Epub 2018 Apr 10. Review.

PMID:
29635792
33.

Cardiovascular disease after transplantation: an emerging role of the immune system.

Van Laecke S, Malfait T, Schepers E, Van Biesen W.

Transpl Int. 2018 Jul;31(7):689-699. doi: 10.1111/tri.13160. Epub 2018 Apr 30. Review.

34.

Can increased vigilance for chronic kidney disease in hospitalised patients decrease late referral and improve dialysis-free survival?

De Wilde M, Speeckaert M, Van Biesen W.

BMC Nephrol. 2018 Apr 2;19(1):74. doi: 10.1186/s12882-018-0869-6.

35.

Is Kt/V useful in elderly dialysis patients? Pro and Con arguments.

Tattersall J, Farrington K, Gentile G, Kooman J, Macias Núñez JF, Nistor I, Van Biesen W, Covic A; European Renal Best Practice Guidelines Group and the European Union of Geriatric Medicine Societies (EUGMS) collaborative group for the production of guidelines on the management of older patients with CKD.

Nephrol Dial Transplant. 2018 May 1;33(5):742-750. doi: 10.1093/ndt/gfy042.

PMID:
29566211
36.

A plea for more uremic toxin research in children with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vanholder R, Vande Walle J, Eloot S.

Pediatr Nephrol. 2018 Jun;33(6):921-924. doi: 10.1007/s00467-018-3920-8. Epub 2018 Mar 2. No abstract available.

PMID:
29500629
37.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
38.

Micro-computed tomography for the quantification of blocked fibers in hemodialyzers.

Vanommeslaeghe F, Van Biesen W, Dierick M, Boone M, Dhondt A, Eloot S.

Sci Rep. 2018 Feb 8;8(1):2677. doi: 10.1038/s41598-018-20898-w.

39.

Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.

Schepers E, Glorieux G, Eloot S, Hulko M, Boschetti-de-Fierro A, Beck W, Krause B, Van Biesen W.

BMC Nephrol. 2018 Jan 5;19(1):1. doi: 10.1186/s12882-017-0808-y.

40.

Caring for Migrants and Refugees With End-Stage Kidney Disease in Europe.

Van Biesen W, Vanholder R, Ernandez T, Drewniak D, Luyckx V.

Am J Kidney Dis. 2018 May;71(5):701-709. doi: 10.1053/j.ajkd.2017.10.015. Epub 2017 Dec 21.

PMID:
29274918
41.

Composing a new song for trials: the Standardized Outcomes in Nephrology (SONG) initiative.

Tong A, Craig JC, Nagler EV, Van Biesen W; SONG Executive Committee and the European Renal Best Practice Advisory Board; SONG Executive Committee and the European Renal Best Practice Advisory Board.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1963-1966. doi: 10.1093/ndt/gfx288. No abstract available.

PMID:
29126280
42.

Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis.

Nistor I, De Sutter J, Drechsler C, Goldsmith D, Soler MJ, Tomson C, Wiecek A, Donciu MD, Bolignano D, Van Biesen W, Covic A.

Nephrol Dial Transplant. 2018 Jan 1;33(1):12-22. doi: 10.1093/ndt/gfx072. Review.

PMID:
29106631
43.

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.

Eloot S, Van Biesen W, Roels S, Delrue W, Schepers E, Dhondt A, Vanholder R, Glorieux G.

PLoS One. 2017 Oct 10;12(10):e0186010. doi: 10.1371/journal.pone.0186010. eCollection 2017.

44.

Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.

Snauwaert E, Van Biesen W, Raes A, Glorieux G, Van Bogaert V, Van Hoeck K, Coppens M, Roels S, Vande Walle J, Eloot S.

Nephrol Dial Transplant. 2018 Jun 1;33(6):978-986. doi: 10.1093/ndt/gfx224.

PMID:
28992139
45.

Further approaches to reduce the cost of renal replacement therapy.

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Van Biesen W, Zoccali C; European Kidney Health Alliance.

Nat Rev Nephrol. 2017 Nov;13(11):720. doi: 10.1038/nrneph.2017.136. Epub 2017 Sep 25. No abstract available.

PMID:
28944776
46.

Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.

Snauwaert E, Van Biesen W, Raes A, Holvoet E, Glorieux G, Van Hoeck K, Van Dyck M, Godefroid N, Vanholder R, Roels S, Walle JV, Eloot S.

Pediatr Nephrol. 2018 Feb;33(2):315-323. doi: 10.1007/s00467-017-3802-5. Epub 2017 Sep 22.

PMID:
28939943
47.

The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.

Van Biesen W, Vanholder R, Schepers E, Glorieux G, Dhondt A, Eloot S.

Contrib Nephrol. 2017;191:168-177. doi: 10.1159/000479265. Epub 2017 Sep 14. Review.

PMID:
28910800
48.

Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial.

Van Laecke S, Caluwe R, Huybrechts I, Nagler EV, Vanholder R, Peeters P, Van Vlem B, Van Biesen W.

Ann Transplant. 2017 Aug 29;22:524-531.

49.

Diagnostic and therapeutic approach to peritonitis.

Van Biesen W, Brown EA.

Nephrol Dial Transplant. 2017 Aug 1;32(8):1283-1284. doi: 10.1093/ndt/gfx226. No abstract available.

PMID:
28810726
50.

Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation: a case report.

Steyaert S, Van Dorpe J, Hoorens A, Van Biesen W, Van Laecke S.

Acta Clin Belg. 2018 Jun;73(3):229-232. doi: 10.1080/17843286.2017.1361622. Epub 2017 Aug 14.

PMID:
28805142

Supplemental Content

Loading ...
Support Center